BackInter Pharma Public Company Limited Overview
Inter Pharma Public Company Limited

Inter Pharma Public Company Limited P/E Ratio

Latest P/E ratio for Inter Pharma Public Company Limited: 21.5 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

21.50

P/E Ratio

21.50

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Inter Pharma Public Company Limited (IP.BK) FAQ

As of the most recent data, IP.BK shows a P/E ratio of 21.5. That is below the Healthcare sector average of 21.65. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/E ratio is about 21.65. Inter Pharma Public Company Limited is at 21.5, which is lower that average. That is roughly 0.7% below the sector mean. Use the comparison chart on this page to see how IP.BK stacks up against individual peers as well.

Investors watch IP.BK's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Inter Pharma Public Company Limited's latest reading is 21.5. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Inter Pharma Public Company Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 21.5) with ownership activity and broader fundamentals.

The Healthcare average P/E ratio is about 21.65, while IP.BK is at 21.5. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers